Histomorphology of the bottlenose dolphin (Tursiops truncatus) pancreas and association of increasing islet β-cell size with chronic hypercholesterolemia.
Bottlenose dolphins (Tursiops truncatus) can develop metabolic states mimicking prediabetes, including hyperinsulinemia, hyperlipidemia, elevated glucose, and fatty liver disease. Little is known, however, about dolphin pancreatic histomorphology. Distribution and area of islets, α, β, and δ cells were evaluated in pancreatic tissue from 22 dolphins (mean age 25.7years, range 0-51). Associations of these measurements were evaluated by sex, age, percent high glucose and lipids during the last year of life, and presence or absence of fatty liver disease and islet cell vacuolation. The most common pancreatic lesions identified were exocrine pancreas fibrosis (63.6%) and mild islet cell vacuolation (47.4%); there was no evidence of insulitis or amyloid deposition, changes commonly associated with type 2 diabetes. Dolphin islet architecture appears to be most similar to the pig, where α and β cells are localized to the central or periphery of the islet, respectively, or are well dispersed throughout the islet. Unlike pigs, large islets (greater than 10,000μm(2)) were common in dolphins, similar to that found in humans. A positive linear association was identified between dolphin age and islet area average, supporting a compensatory response similar to other species. The strongest finding in this study was a positive linear association between islet size, specifically β-cells, and percent blood samples with high cholesterol (greater than 280mg/dl, R(2)=0.57). This study is the most comprehensive assessment of the dolphin pancreas to date and may help direct future studies, including associations between chronic hypercholesterolemia and β-cell size.
Zoological Pathology Program, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, LUMC, Building 101, Room 0745, Maywood, IL 60153, USA. Electronic address: katie.colegrove@gmail.com.
Kathleen M
KM
Colegrove
Translational Medicine and Research Program, National Marine Mammal Foundation, 2240 Shelter Island Suite 200, San Diego, CA 92106, USA. Electronic address: stephanie.venn-watson@nmmf.org.
Stephanie
S
Venn-Watson
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D050681:Bottle-Nosed Dolphin / Q000378:metabolism*; D048429:Cell Size; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D005234:Fatty Liver / Q000378:metabolism / Q000473:pathology / Q000662:veterinary*; D005260:Female; D006937:Hypercholesterolemia / Q000378:metabolism / Q000473:pathology / Q000662:veterinary*; D007150:Immunohistochemistry; D007515:Islets of Langerhans / Q000378:metabolism / Q000473:pathology*; D008297:Male; D010179:Pancreas / Q000378:metabolism / Q000473:pathology*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D014280:Triglycerides; D002784:Cholesterol
Bottlenose dolphin; Diabetes; Hypercholesterolemia; Insulin resistance; Islet cells; Pancreas